Teligent receives FDA approval for Clobetasol Propionate Ointment ANDA

Teligent announced it has received approval of the company’s abbreviated new drug application, or ANDA, from the FDA of Clobetasol Propionate Ointment. This is Teligent’s first approval of 2019, and its thirty-third approval from its internally-developed pipeline of topical generic pharmaceutical medicines.
https://thefly.com/landingPageNews.php?id=2853117